Proactive News Highlights: Aminex, Amedeo Resources, Alliance Pharma, Constellation Healthcare and more...
A round up of the day's news from Proactive Investors.
Company
EMV Capital
LON:NSCI
EMV Capital plc is a deep tech and life sciences venture capital investment group with an international portfolio of high-growth companies. With a strategic focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future, the group invests in, manages, and strengthens early stage IP-rich companies.
424 stories · page 20 of 22
NetScientific’s Wanda chosen by 24Hr HomeCare
24Hr HomeCare will use Wanda’s predictive analytics and behavioural guidance technology to help monitor the health of its patients
Risers & Fallers: Seeing Machines, Scotgold, GCM Resources ...
Significant share price risers and fallers in London at 4.15pm
NetScientific's Glycotest granted Japanese patent for liver disease test
The Japanese patent joins five others previously granted across Australia, US and Japan.
NetScientific’s Wanda appoints new non-exec
NetScientific’s portfolio company Wanda has appointed healthcare industry veteran Derek Newell to its board as non-executive director
Proactive news highlights: Bass Metals, Fox Marble, Netscientific and Stratmin Global
Fox Marble hit by currency fluctuations, Netscientific launches a phone app and Stratmin shareholders look forward to impending Graphmada sale.
App-y days as NetScientific’s portfolio company Wanda launches phone app
The app aims to empower women to improve the health of their hearts by offering support, education and guidance
Proactive news highlights: Forbidden Technologies, Netscientific, Rare Earth, StatPro and more...
Telit is collaborating with Indian information tech specialist, Vortex Biosciences granted licences for cell electroporation and Forbidden Technologies signs with a sports content group.
NetScientific investee company strikes Harvard licensing deal
Vortex Biosciences has been granted a series of licences for cell electroporation technology developed by Harvard researchers that will boost its ability to analyse circulation tumour cells (CTCs).
Proactive news highlights: ANGLE, Eckoh, Netscientific, Quartix, Savannah, W Resources and more...
W Resources kicks off its Spanish ambitions with a bang, ATTRAQT continues to see strong uptake and Eurasia Mining expects to produce the first concentrate from its West Kytlim alluvial platinum prospect.
Netscientific hails Wanda’s new medical director
Netscientific hailed the appointment of a renowned cardiologist as medical director at its portfolio firm Wanda.
NetScientific ‘totally revitalised’ under Francois Martelet, says chairman Sir Richard Sykes
“We now have a focused portfolio of assets which are close to commercialisation and which offer the scope for significant value creation,” Sykes said ahead of a Capital Markets Day.
Allergy Therapeutics appoints ex- Skyepharma man as FD
Peter Jensen, Allergy’s chairman said Wykeham’s experience in life sciences was well suited to Allergy.
NetScientific invests in PDS Biotech
NetScientific has ploughed a further US$500,000 in the immuno-oncology company after originally investing in PDS Biotechnology back in 2014.
Proactive news highlights: Amur Minerals, Beowulf Mining, Hurricane Energy, SolGold and more
Stratex is on course to hit targets, Beowulf thrown into disarray over Environmental report and Fastnet is to rename...
NetScientific portfolio company to present at prestigious cancer conference
Vortex will present data at the AACR that demonstrates the ability of its technology to rapidly collect highly enriched populations of circulating tumour cells
NetScientific buoyed by trial results; to spend further $500k
The phase I study looked at the method of action of the Versamune technology behind the treatment.
NetScientific PLC unveils Ian Postlethwaite as new CFO
We knew Postlethwaite was leaving Allergy Therapeutics after 14 years; now we know where he is going to
Week Ahead: Keywords Studios PLC going for new high score
The February trading update sent analysts scurrying to their calculators to upgrade their forecasts
NetScientific PLC's ProAxsis sets up scientific advisory board
The advisory board will support ProAxsis in the development of its Proteasetag activity-based immunoassays and point-of-care tests